Nicole Lambert
Fortune : 1 M $ au 31/08/2026
Fortune : 1 M $ au 31/08/2026
Ms. Nicole Lambert is an Independent Director at Arcus Biosciences, Inc. and a President at Myriad Genetic Laboratories, Inc. She is on the Board of Directors at Arcus Biosciences, Inc. Ms. Lambert was previously employed as a Chief Operating Officer by Myriad Genetics, Inc. She received her undergraduate degree from Boston College and a graduate degree from Icahn School of Medicine at Mount Sinai.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 11/06/2026 | 43 000 ( 0,03% ) | 1 M $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ARCUS BIOSCIENCES, INC. | Directeur/Membre du Conseil | 03/08/2021 |
Myriad Genetic Laboratories, Inc.
Myriad Genetic Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Provides cancer predisposition testing services | President | - |
| Sociétés | Poste | Fin |
|---|---|---|
| MYRIAD GENETICS, INC. | Directeur des opérations | 31/10/2023 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Myriad Genetics, Inc.
Myriad Genetics, Inc. Medical SpecialtiesHealth Technology Develops therapeutic and predictive medicine products | Health Technology |
Boston College
Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Myriad Genetic Laboratories, Inc.
Myriad Genetic Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Provides cancer predisposition testing services | Commercial Services |
Arcus Biosciences, Inc.
Arcus Biosciences, Inc. BiotechnologyHealth Technology Develops and commercializes novel therapies for the treatment of lung & gastrointestinal cancers | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national